If you’re a member of the media working on a story about brain trauma or brain health, we can connect you with the experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Follow Cohen Veterans Bioscience
- Read more
New results from the PPMI Data Modeling Core reveal the power of digital health technologies to remotely detect motor symptoms of Parkinson’s Disease.
Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership RoleRead more
Peter Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development, and Impact. In this newly created role, Hoehn will lead the External Affairs, Communications, and Development functions for New York-based non-profit CVB which is dedicated to advancing brain health.
- Read more
Cohen Veterans Bioscience is proud to introduce an unprecedented new video series that provides the practical knowledge necessary for researchers to incorporate sex as a biological variable into their current and future research. The 18-part video training program was developed to help strengthen the translation of basic research findings to human care.
The Global Preclinical Data Forum, Cohen Veterans Bioscience and European College of Neuropsychopharmacology Announce 2022 Best Negative Data Prize in Preclinical NeuroscienceRead more
The Global Preclinical Data Forum, in collaboration with Cohen Veterans Bioscience and the European College of Neuropsychopharmacology, announce the opening of submissions for the 2022 Best Negative Data Prize in Preclinical Neuroscience. The prize recognizes the researcher or research group whose publication in preclinical neuroscience best exemplifies data where the results do not confirm the expected outcomes or original hypotheses.
Traumatic Brain Injury: A Framework to Advance Biomarker Development for Diagnosis, Outcome Prediction, and TreatmentRead more
Published in the Journal of Neurotrauma, the article focuses on the pressing need for multi-modal biomarkers for traumatic brain injury to guide the development of diagnostics and personalized, targeted therapies.